Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Centers for Medicare & Medicaid Services (CMS)
Pharma
With Chevron gone, multitude of legal challenges await FDA, CMS
An expert recently discussed the ramifications of the Supreme Court's Chevron doctrine ruling during a Fierce Pharma podcast interview.
Kevin Dunleavy
Aug 27, 2024 8:40am
IRA negotiations slash prices for blockbuster drugs by up to 79%
Aug 15, 2024 9:00am
Leqembi, Takeda, Fujifilm Diosynth—Fierce Pharma Asia
Apr 19, 2024 9:20am
HHS responds to Big Pharma's IRA counteroffers
Apr 3, 2024 11:18am
Drugmakers counter HHS' first offers in Medicare price talks
Mar 4, 2024 4:09pm
ICER chief lays out requirement for more IRA involvement
Jan 30, 2024 3:15pm